Brefel C, Thalamas C, Rayet S, Lopez-Gil A, Fitzpatrick K, Bullman S, Citerone DR, Taylor AC, Montastruc JL, Rascol O. Effect of food on the pharmacokinetics of ropinirole in parkinsonian patients.
Br J Clin Pharmacol 1998;
45:412-5. [PMID:
9578193 PMCID:
PMC1873962 DOI:
10.1046/j.1365-2125.1998.t01-1-00704.x]
[Citation(s) in RCA: 21] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/07/1997] [Accepted: 12/04/1997] [Indexed: 02/07/2023] Open
Abstract
AIMS
Ropinirole is a specific non-ergoline dopamine D2-receptor agonist with antiparkinsonian properties. The pharmacokinetic parameters of ropinirole taken in the fasted condition were compared with those when it was co-administered with food.
METHODS
This was an open, randomized, two sessions cross over study in 12 patients with Parkinson's disease, comparing the steady-state pharmacokinetic profiles of ropinirole on two different study days: 'fasted' and 'fed'.
RESULTS
The mean Cmax was lower in the 'fed' regimen than in the 'fasted' one (-25%, P=0.002). The median tmax was observed 2.6 h later in the 'fed' regimen than in the 'fasted' regimen (P<0.05). There was a slight but significant decrease in AUC(0,8 h) in the 'fed' regimen (P=0.03).
CONCLUSIONS
Food decreases the rate of absorption of ropinirole, but has little effect on the extent of absorption.
Collapse